查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1532976

聚合物添加劑市場－2024年至2029年預測

Polymer Excipients Market - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 141 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計在預測期（2024-2029年）聚合物添加劑市場將以4.27%的複合年成長率成長。

聚合物添加劑市場可以定義為源自合成和天然聚合物的藥物製劑成分的快速開拓領域。藥物傳遞系統中的重要賦形劑可提高藥物的穩定性和功效。

聚合物賦形劑在藥物傳遞系統中的靈活用途包括控制釋放製劑、封裝、錠劑包衣以及與生技藥品綴合以提高溶解度。它也用於生產藥用油墨、製備著色劑和顏料、化妝品以及高級傷口護理。這是由於對藥物輸送新技術的需求不斷成長、疾病發病率上升以及患者依從性提高而推動的。

  • 聚合物添加劑市場呈上升趨勢，背後有幾個原因。 TSWI 將世界對新型藥物輸送系統的需求視為主要成長要素之一。隨著製藥業先進治療方法的增加，對藥物穩定性、生物有效性和功效方面性能更好的輔料的需求也不斷增加。涉及控制釋放系統、封裝和與生技藥品綴合的聚合物添加劑對於建構最先進的藥物傳遞系統至關重要。這種需求是由慢性病的增加和提高患者依從性的需求所驅動的。
  • 促進市場成長的另一個因素是全球學名藥的使用不斷增加。市場正在見證學名藥的進入，其中許多學名藥以前由於專利保護失效而成為品牌藥的專屬領域。因此，輔料支持學名藥的品質、安全性和有效性。在這方面，聚合物賦形劑是重要的製劑成分，可增強化學和物理穩定性，從而增強學名藥中所含治療劑的功效。預計這一趨勢將持續下去，對聚合物添加劑的需求將進一步增加，刺激聚合物添加劑市場的成長。

聚合物添加劑細分市場分析：

  • 聚乙烯吡咯烷酮產業將是預測期內成長最快的產業。

在所有聚合物添加劑中，聚乙烯吡咯烷酮（PVP）領域預計將成為預測期內特定市場中成長最快的領域。這是由於 PVP 在製藥業中的使用越來越多，因為它具有相當專業的用途和特性。聚維酮（PVP）是一種合成聚合物，被認為是各種製劑中的重要賦形劑。易於人體吸收、溶解性、成膜性和滲透性等特性使其成為業界流行的添加劑。

PVP 常用於生產錠劑、膠囊、糖漿、滅菌劑、消毒劑和注射劑。它們在藥物製劑中充當粘合劑、崩壞、增溶劑和穩定劑，並作為提高藥物穩定性、生物有效性和功效的重要佐劑。

近年來，由於慢性病等健康併發症以及藥物輸送系統的技術進步，對 PVP 的需求增加。隨著製藥工業的進步以及更多特異性和有效藥物的開發，對用於提高藥物效率的賦形劑的需求增加。隨著循環系統領域患者服務的普遍化以及對更複雜和個人化的慢性疾病管理方法的需求，適應各種類型藥物配方的PVP將滿足這些未來的需求。生物製藥製造和 COVID-19 疫苗開發等新趨勢也創造了對 PVP 的需求。在這次大流行期間，輔料在此類基本藥物的配方和製造中的作用變得更加重要，導致市場大幅成長。

  • 粘合劑市場似乎是預測期內成長最快的細分市場。

從上述分析可以得出結論，在預測期內，粘合劑部分可能是全球聚合物添加劑市場中成長最快的。這可能與用於改善藥品物理和化學性質的粘合劑市場規模不斷成長有關。聚合物添加劑屬於粘合劑類別，用於製備固態劑型，包括錠劑和膠囊。粘合劑賦予配方彈性、拉伸強度和黏合成分，並有助於在儲存和運輸過程中保持其黏合和品質。也就是說，粘合劑可以溶液的形式或粉末的形式用於直接壓片以用於特定的藥物製劑。

由於慢性疾病的增加和藥物輸送方法的改進，粘合劑在製藥行業中的使用增加。現代製藥工業的特點是生產高度專業化的藥物，需要有效的輔料來進一步提高其性能。透過改善配方的物理和化學性能，粘合劑可以有效地滿足這種增加的需求。

生物製藥領域的趨勢和對 COVID-19 疫苗的需求正在推動粘合劑消費的增加。 COVID-19 危機的重點是藥物配方和市場開拓中使用的輔料，推動了市場的重大發展。

  • 預計亞太地區將在預測期內主導聚合物添加劑市場。

由於幾個關鍵因素，預計亞太地區將在預測期內主導聚合物添加劑市場。其主要原因是亞太地區正在不斷開拓的醫藥市場對聚合物添加劑的需求不斷增加。如果我們看一下中國和印度的案例，就會發現慢性病的增加、人口老化和醫療保健機會的增加正在改變藥物生產和消費中藥物提取的梯度。隨著藥品製造業的發展，藥物配方中必不可少的聚合物添加劑的使用也不斷發展。

該地區對學名藥的需求呈現高速成長，推動了聚合物添加劑市場的發展。當今的學名藥製造商主要依靠賦形劑來確保其產品安全有效。聚合物賦形劑也因其在提高學名藥的穩定性和生物有效性方面的優勢而在這個龐大的新興市場中獲得認可。

亞太地區個人化藥物治療的日益成長趨勢以及新型藥物傳輸系統的進步正在推動聚合物添加劑市場的發展。由於其配方組成的靈活性，聚合物添加劑有潛力滿足該地區現有和新興市場的需求。

此外，亞太地區生物製藥產業的成長和 COVID-19 疫苗的發明也增加了輔料在救命藥物生產中的使用。隨著生產商擴大他們的研究興趣以滿足不斷成長的市場，這有助於為聚合物添加劑市場帶來一些改進。由於這些因素，由於製藥業的快速成長、學名藥、個人化藥物的興起以及新藥物輸送系統的進步，亞太地區在預測期內引領聚合物賦形劑市場。

聚合物添加劑市場細分與分析如下：

依產品類型

  • 聚乙烯吡咯烷酮
  • 聚乙二醇
  • 澱粉
  • 結晶纖維素（MCC）
  • 乙基和甲基纖維素
  • 羥丙基甲基纖維素（HPMC）
  • 其他

按用途

  • 粘合劑
  • 黏度調節劑
  • 塗層
  • 香味
  • 防腐劑
  • 色素
  • 甜味劑
  • 其他

按地區

  • 北美洲
  • 美國
  • 加拿大
  • 墨西哥
  • 南美洲
  • 巴西
  • 阿根廷
  • 其他
  • 歐洲
  • 英國
  • 德國
  • 法國
  • 義大利
  • 西班牙
  • 其他歐洲國家
  • 中東/非洲
  • 沙烏地阿拉伯
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東/非洲
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 台灣
  • 泰國
  • 印尼
  • 其他亞太地區

目錄

第1章簡介

  • 市場概況
  • 市場定義
  • 調查範圍
  • 市場區隔
  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要利益

第2章調查方法

  • 研究設計
  • 調查過程

第3章執行摘要

  • 主要發現
  • 分析師觀點

第4章市場動態

  • 市場促進因素
    • 不斷發展的製藥業
    • 塗料應用對聚合物添加劑的需求增加
  • 市場限制因素
    • 監管機構的嚴格規定
    • 考慮滿足產品品質要求
    • 來自替代品的威脅
  • 波特五力分析
  • 產業價值鏈分析

第5章聚合物添加劑市場：依產品類型

  • 介紹
  • 聚乙烯吡咯烷酮
  • 聚乙二醇
  • 澱粉
  • 結晶纖維素（MCC）
  • 乙基和甲基纖維素
  • 羥丙基甲基纖維素（HPMC）
  • 其他

第6章聚合物添加劑市場：依應用分類

  • 介紹
  • 粘合劑
  • 黏度調節劑
  • 塗層
  • 香味
  • 防腐劑
  • 著色劑
  • 甜味劑
  • 其他

第7章聚合物添加劑市場：按地區

  • 世界概況
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 其他歐洲國家
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東/非洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 台灣
    • 泰國
    • 印尼
    • 其他亞太地區

第8章競爭環境及分析

  • 主要企業及策略分析
  • 市場佔有率分析
  • 合併、收購、協議和合作
  • 競爭對手儀表板

第9章 公司簡介

  • ABITEC
  • ADM
  • Ashland
  • BASF SE
  • Cargill, Incorporated.
  • Colorcon
  • Croda International Plc
  • DFE Pharma
  • Dow
  • DuPont
  • Eastman Chemical Company
  • Evonik Industries AG
  • FINAR LIMITED
  • JRS PHARMA
  • Kerry Inc.
  • Roquette Freres
  • The Lubrizol Corporation
簡介目錄
Product Code: KSI061616983

The polymer excipients market is expected to grow at a CAGR of 4.27% during the forecast period (2024-2029).

The polymer excipients market can be defined as the rapidly developing field of components for pharmaceutical formulations originating from synthetic and natural polymers. The following are some of the excipients that are important in drug delivery systems; they improve the stability and efficacy of pharmaceutical products.

The flexible use of polymer excipients in drug delivery systems includes controlled release formulations, encapsulation, coating of tablets, and conjugation to biologics to improve solubility. They are also employed in the production of pharmaceutical inks, the preparation of colorants and pigments, cosmetics, and advanced wound care items. This is due to the enhanced need for new technologies in drug delivery, the rising incidence of diseases, and strict patient compliance.

  • The polymer excipients market is on an upward trend and there are several reasons that have attributed to the above trend. TSWI has identified one of the large growth factors as being the global need for new drug delivery systems. With the increase of advanced therapies in the pharmaceutical industry, so is the requirement for excipients with better performance in stability, bioavailability, and effectiveness of the drugs. Polymer excipients that are involved in the controlled release systems, encapsulation, and conjugation to the biologics are critical to incorporate in creating state-of-the-art drug delivery systems. This need is heightened by the increasing incidence of chronic ailments and the necessity to enhance adherence among patients.
  • Another avenue for expanding the firm's growth is the increasing use of generic medicines globally. The market is witnessing the entry of generics, many of which were earlier solely in the domain of branded drugs due to the expiry of patent protection. As such, excipients are the backbone of generic drugs' quality, safety, and efficacy. In this regard, polymer excipients are significant formulating components that can enhance the chemical and physical stability and, therefore, the efficacy of the therapeutic agents contained in generic products. It is believed that this trend will persist in future years, and the need for polymer excipients will be even higher, stimulating the polymer excipients market's growth.

POLYMER EXCIPIENTS MARKET SEGMENT ANALYSIS:

  • The Polyvinylpyrrolidone segment will likely be the fastest-growing segment during the forecast period.

Out of all the polymer excipients, the polyvinylpyrrolidone (PVP) segment is predicted to be the fastest-growing segment in the identified market for the duration of the forecast year. This can be attributed to the rise in the usage of PVP in the pharmaceutical industry because of its fairly special uses and characteristics. Povidone, which is identified as PVP, is a synthetic polymer that is regarded as an essential excipient in different types of formulations. Ease of absorption into the body, as well as such qualities as solubility and film-forming properties and the organism's impermeability - all these make it a popular additive in the industry.

PVP is usually used in the production of tablets, capsules, syrup, sterilization, disinfection, and injection. It functions as a binder, disintegrant, solubilizer, and stabilizer in drug formulations, thus acting as an important adjuvant in improving the stability, bioavailability, and effectiveness of pharmaceuticals.

The need for PVP has risen in recent years due to health complications such as chronic diseases and enhancements of techniques in drug delivery systems. With the progression of the pharmaceutical industry and the creation of more specific, effective medication the need for excipients rises as they play the role of improving drug efficiency. The generalization of patient services and the need for more sophisticated and individualized approaches in the management of chronic disease in the field of cardiovascular therapy allows PVP, which can be adapted to different types of drug formulations, to meet these future needs. The new tendencies, such as the biopharmaceuticals production and the COVID-19 vaccine development, also create demand for PVP. The role of excipients as ingredients in the formulation and manufacturing of such essential drugs has been more emphasized during this pandemic, and as a result, great achievements have been made on the market.

  • The Binders segment will likely be the fastest-growing segment during the forecast period.

Based on the above analysis, it can be concluded that the binders segment is likely to grow at the fastest rate in the global polymer excipients market over the forecasting period. This may be related to the rising market size for binders in the pharma, which is used to enhance the physical and chemical characteristics of drug products. Polymer excipients belong to the category of binders and are employed in the preparation of solid dosage forms including tablets and capsules. They assist in conveying elasticity, tensile strength, and a bonded composition to the formulation of the product to stay united and preserve its quality during storage or transport. This means that binders can be employed in solution form or as a powder for direct compaction for that specific formulation of drugs.

The rising usage of binders in the pharmaceutical industry is attributed to the rise in chronic ailments and improved drug delivery methods. The modern pharmaceutical industry is characterized by the production of highly specialized medicines, which require effective excipients to further boost their performance. By enhancing the physical and chemical characteristics of drug formulations, binders can effectively address this increasing demand.

The global trend of biopharmaceuticals and the need for the COVID-19 vaccine have caused increased binders consumption. The COVID-19 crisis has brought focus to excipients used in medicinal formulation and development, catalyzing significant market progress.

  • The Asia Pacific region will dominate the polymer excipients market during the forecast period.

The Asia Pacific region is expected to dominate the polymer excipients market during the forecast period, driven by several key factors. The primary reason is the increasing demand for polymer excipients in the continuously developing pharmaceutical market in the Asia Pacific area. From the cases of China and India, there has been a change in slope regarding the abstraction of pharmaceutical products through the production and consumption of the same due to the increased prevalence of chronic diseases, an aging population, and more access to healthcare. As the industry of manufacturing drugs evolves, the use of polymer excipients, which are crucial in drug formulation, also increases.

This region is experiencing high growth in the demand for generics, boosting the polymer excipients market. Today's generic drug makers depend mostly on excipients to make their products safe and effective for their users. Polymer excipients are well accepted in this large and emerging market because of their advantages in terms of improved stability and bioavailability of generic drugs.

The increasing trend of personalized medications, along with the advances in new drug delivery systems in the Asia Pacific region, have boosted the polymer excipients market. Because of their flexibility in the composition of drug formulations, polymer excipients have good potential for meeting the existing and emerging market needs in this region.

In addition, the growth of the biopharmaceutical sector and the invention of the COVID-19 vaccine in the Asia Pacific region have also increased the application of excipients in manufacturing life-saving medicines. This has helped bring several improvements in the polymer excipients market because producers expand their concerns on research to conform to the ever-growing market. Owing to these factors, the Asia Pacific area leads the polymer excipients market within the forecast period because of the fast-growing pharmaceutical industry, the increasing scope of generics, individualized medications, and the advancement of new drug delivery systems.

The polymer excipients market is segmented and analyzed as follows:

By Product Type

  • Polyvinylpyrrolidone
  • Polyethylene Glycol
  • Starch
  • Micro Crystalline Cellulose (MCC)
  • Ethyl and Methyl Cellulose
  • Hydroxypropyl Methylcellulose (HPMC)
  • Others

By Application

  • Binders
  • Viscosity Modifiers
  • Coatings
  • Flavors
  • Preservatives
  • Colorants
  • Sweeteners
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Middle East and Africa
  • Saudi Arabia
  • Saudi Arabia
  • United Arab Emirates
  • Rest of the Middle East and Africa
  • Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Rest of Asia-Pacific

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key benefits for the stakeholders

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Process

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings
  • 3.2. Analyst View

4. MARKET DYNAMICS

  • 4.1. Market Drivers
    • 4.1.1. Growing Pharmaceutical Industry
    • 4.1.2. Rising Demand for Polymer Excipients from Coatings Application
  • 4.2. Market Restraints
    • 4.2.1. Stringent Rules by Regulatory Bodies
    • 4.2.2. Concerns to Meet the Required Quality of Product
    • 4.2.3. Threats from Substitutes
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. The Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. POLYMER EXCIPIENTS MARKET BY PRODUCT TYPE

  • 5.1. Introduction
  • 5.2. Polyvinylpyrrolidone
  • 5.3. Polyethylene Glycol
  • 5.4. Starch
  • 5.5. Micro Crystalline Cellulose (MCC)
  • 5.6. Ethyl and Methyl Cellulose
  • 5.7. Hydroxypropyl Methylcellulose (HPMC)
  • 5.8. Others

6. POLYMER EXCIPIENTS MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Binders
  • 6.3. Viscosity Modifiers
  • 6.4. Coatings
  • 6.5. Flavors
  • 6.6. Preservatives
  • 6.7. Colorants
  • 6.8. Sweeteners
  • 6.9. Others

7. POLYMER EXCIPIENTS MARKET BY GEOGRAPHY

  • 7.1. Global Overview
  • 7.2. North America
    • 7.2.1. United States
    • 7.2.2. Canada
    • 7.2.3. Mexico
  • 7.3. South America
    • 7.3.1. Brazil
    • 7.3.2. Argentina
    • 7.3.3. Rest of South America
  • 7.4. Europe
    • 7.4.1. United Kingdom
    • 7.4.2. Germany
    • 7.4.3. France
    • 7.4.4. Italy
    • 7.4.5. Spain
    • 7.4.6. Rest of Europe
  • 7.5. Middle East and Africa
    • 7.5.1. Saudi Arabia
    • 7.5.2. United Arab Emirates
    • 7.5.3. Rest of Middle East and Africa
  • 7.6. Asia-Pacific
    • 7.6.1. China
    • 7.6.2. India
    • 7.6.3. Japan
    • 7.6.4. South Korea
    • 7.6.5. Taiwan
    • 7.6.6. Thailand
    • 7.6.7. Indonesia
    • 7.6.8. Rest of Asia-Pacific

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 8.1. Major Players and Strategy Analysis
  • 8.2. Market Share Analysis
  • 8.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 8.4. Competitive Dashboard

9. COMPANY PROFILES

  • 9.1. ABITEC
  • 9.2. ADM
  • 9.3. Ashland
  • 9.4. BASF SE
  • 9.5. Cargill, Incorporated.
  • 9.6. Colorcon
  • 9.7. Croda International Plc
  • 9.8. DFE Pharma
  • 9.9. Dow
  • 9.10. DuPont
  • 9.11. Eastman Chemical Company
  • 9.12. Evonik Industries AG
  • 9.13. FINAR LIMITED
  • 9.14. JRS PHARMA
  • 9.15. Kerry Inc.
  • 9.16. Roquette Freres
  • 9.17. The Lubrizol Corporation